April 29, 2020 / 12:44 PM / a month ago

BRIEF-Ani Receives Refusal To File Letter From FDA For Cortrophin® Gel

April 29 (Reuters) - ANI Pharmaceuticals Inc:

* ANI RECEIVES REFUSAL TO FILE LETTER FROM FDA FOR CORTROPHIN® GEL

* ANI PHARMACEUTICALS INC - WILL SEEK IMMEDIATE GUIDANCE, WHICH POTENTIALLY INCLUDES REQUESTING A TYPE A MEETING WITH FDA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below